Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CEFSINT trial of ceftriaxone versus tobramycin combinations in neonates with serious bacterial infection
NL-OMON37438Withdrawn
- Sponsor
- Elisabeth-TweeSteden Ziekenhuis
- Start
- Jun 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial in bacterial disease comparing Ceftriaxone + amoxicillin-clavulanic acid with Tobramycin + amoxicillin-clavulanic acid (2 arms). Primary endpoint: Incidence of hyperbilirubinemia. Planned start Jun 2012; status: withdrawn.
02
Drugs
ceftriaxonetobramycinamoxicillin + clavulanate
03
Conditions
bacterial disease
Beyond the preview
Go deeper on NL-OMON37438.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON37438.